JP2013522370A5 - - Google Patents

Download PDF

Info

Publication number
JP2013522370A5
JP2013522370A5 JP2013501403A JP2013501403A JP2013522370A5 JP 2013522370 A5 JP2013522370 A5 JP 2013522370A5 JP 2013501403 A JP2013501403 A JP 2013501403A JP 2013501403 A JP2013501403 A JP 2013501403A JP 2013522370 A5 JP2013522370 A5 JP 2013522370A5
Authority
JP
Japan
Prior art keywords
compound
pharmaceutical composition
formula
biological condition
lack
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013501403A
Other languages
English (en)
Japanese (ja)
Other versions
JP5931845B2 (ja
JP2013522370A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/029452 external-priority patent/WO2011119622A1/en
Publication of JP2013522370A publication Critical patent/JP2013522370A/ja
Publication of JP2013522370A5 publication Critical patent/JP2013522370A5/ja
Application granted granted Critical
Publication of JP5931845B2 publication Critical patent/JP5931845B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013501403A 2010-03-23 2011-03-22 2−メチレン−19−ノル−22−メチル−1α,25−ジヒドロキシビタミンD3のジアステレオマー Expired - Fee Related JP5931845B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US31665310P 2010-03-23 2010-03-23
US61/316,653 2010-03-23
PCT/US2011/029452 WO2011119622A1 (en) 2010-03-23 2011-03-22 DIASTEREOMERS OF 2-METHYLENE-19-NOR-22-METHYL-1α,25- DIHYDROXYVITAMIN D3

Publications (3)

Publication Number Publication Date
JP2013522370A JP2013522370A (ja) 2013-06-13
JP2013522370A5 true JP2013522370A5 (cg-RX-API-DMAC7.html) 2014-05-08
JP5931845B2 JP5931845B2 (ja) 2016-06-08

Family

ID=44170381

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013501403A Expired - Fee Related JP5931845B2 (ja) 2010-03-23 2011-03-22 2−メチレン−19−ノル−22−メチル−1α,25−ジヒドロキシビタミンD3のジアステレオマー

Country Status (6)

Country Link
US (1) US20110237557A1 (cg-RX-API-DMAC7.html)
EP (1) EP2556054B1 (cg-RX-API-DMAC7.html)
JP (1) JP5931845B2 (cg-RX-API-DMAC7.html)
AU (1) AU2011232562B2 (cg-RX-API-DMAC7.html)
CA (1) CA2793727C (cg-RX-API-DMAC7.html)
WO (1) WO2011119622A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9212137B2 (en) * 2012-05-30 2015-12-15 Wisconsin Alumni Research Foundation Crystallization of (20R,22R)-2-methylene-19-nor-22-methyl-1α,25-dihydroxyvitamin D3 and related precursors
US9539231B2 (en) 2014-01-17 2017-01-10 The Regents Of The University Of Colorado, A Body Corporate Method for treating triple-negative breast cancer using AMPI-109

Family Cites Families (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5246925A (en) * 1989-03-09 1993-09-21 Wisconsin Alumni Research Foundation 19-nor-vitamin D compounds for use in treating hyperparathyroidism
CA1333616C (en) * 1989-03-09 1994-12-20 Hector F. Deluca 19-nor-vitamin d compounds
US5086191A (en) 1991-05-28 1992-02-04 Wisconsin Alumni Research Foundation Intermediates for the synthesis of 19-nor vitamin D compounds
JP3589413B2 (ja) * 1992-03-02 2004-11-17 幸子 山田 22−メチルビタミンd誘導体
DE69400495T2 (de) 1993-04-05 1997-04-30 Wisconsin Alumni Res Found 19-Nor-vitamin-D3-Verbindung mit einem Substituent an die 2. Stelle
US5552392A (en) * 1993-11-03 1996-09-03 Wisconsin Alumni Research Foundation Method of treating hypoparathyroidism with (20S) vitamin D compounds
JP3567223B2 (ja) * 1995-07-31 2004-09-22 幸子 山田 カルシウム代謝改善剤
US5843928A (en) 1997-03-17 1998-12-01 Wisconsin Alumni Research Foundation 2-alkylidene-19-nor-vitamin D compounds
US6316642B1 (en) * 1997-03-17 2001-11-13 Wisconsin Alumni Research Foundation 26,27-Homologated-20-EPI-2alkyl-19-nor-vitamin D compounds
US5945410A (en) * 1997-03-17 1999-08-31 Wisconsin Alumni Research Foundation 2-alkyl-19-nor-vitamin D compounds
US6392071B1 (en) * 1997-03-17 2002-05-21 Wisconsin Alumni: Research Foundation 26,27-homologated-20-EPI-2-alkylidene-19-nor-vitamin D compounds
US6306844B1 (en) * 1997-03-17 2001-10-23 Wisconsin Alumni Research Foundation Use of 2α-methyl-19-nor-20(S)-1α, 25-dihydroxyvitamin D3 to increase bone strength
US6114317A (en) * 1998-05-21 2000-09-05 Wisconsin Alumni Research Foundation Method of locking 1α-OH of vitamin D compounds in axial orientation
AU2001265272B2 (en) * 2000-05-31 2006-08-17 Wisconsin Alumni Research Foundation 2-ethyl and 2-ethylidene-19-nor-vitamin d compounds
AU2001278888B2 (en) * 2000-07-14 2005-04-07 Wisconsin Alumni Research Foundation Use of 2-methylene-19-nor-20(s)-1alpha,25-dihydroxyvitamin D3 to increase bone strength
US6384087B1 (en) * 2000-09-01 2002-05-07 University Of Tennesseee Research Corporation, Inc. Materials and methods for the treatment or prevention of obesity
BR0113703A (pt) * 2000-09-08 2003-07-22 Wisconsin Alumni Researcg Foun Compostos e métodos de tratamento de psorìase, leucemia, câncer do cólon, do seio ou da próstata, osteodistrofia renal, de doenças auto-imune, inflamatória e de condição de pele
US6835723B2 (en) * 2001-12-13 2004-12-28 Wisconsin Alumni Research Foundation 2-methylene-19-nor-20(S)-1α-hydroxy-bis-homo-pregnacalciferol in crystalline form
US6627622B2 (en) * 2002-02-18 2003-09-30 Wisconsin Alumni Research Foundation (20S)-1α-hydroxy-2-methylene-19-nor-bishomopregnacalciferol and its uses
US6566352B1 (en) * 2002-02-18 2003-05-20 Wisconsin Alumni Research Foudation 1 α-hydroxy-2-methylene-19-nor-pregnacalciferol and its uses
DE60310050T2 (de) * 2002-03-29 2007-07-05 Wisconsin Alumni Research Foundation, Madison Ein verfahren zur herstellung von 1-alpha-hydroxy-2-methylen-19-nor-homopregnacalciferol
US6846811B2 (en) * 2002-04-22 2005-01-25 Wisconsin Alumni Research Foundation (20S) 1α-hydroxy-2α-methyl and 2β-methyl-19-nor-vitamin D3 and their uses
US6894037B2 (en) * 2003-07-03 2005-05-17 Wisconsin Alumni Research Foundation 2-methylene-19-nor-20(S)-25-methyl-1α-hydroxycalciferol and its uses
EP1656157B1 (en) * 2003-08-20 2011-12-21 Wisconsin Alumni Research Foundation 2-methylene-19-nor-vitamin d2 compounds
WO2005027913A1 (en) * 2003-09-19 2005-03-31 Pfizer Products Inc. Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and a growth hormone secretagogue
CA2539361A1 (en) * 2003-09-19 2005-03-31 Pfizer Products Inc. Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and an estrogen agonist/antagonist
CA2539357A1 (en) * 2003-09-19 2005-03-31 Pfizer Products Inc. Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and parathyroid hormone
WO2005027931A1 (en) * 2003-09-19 2005-03-31 Pfizer Products Inc. Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and an ep2 or ep4 selective agonist
US7214670B2 (en) * 2003-09-24 2007-05-08 Wisconsin Alumni Research Foundation Use of 2-methylene-19-nor-20(S)-1α,25-dihydroxyvitamin D3 to increase the life expectancy of human beings
US7704980B2 (en) * 2003-10-08 2010-04-27 Wisconsin Alumni Research Foundation Treatment of inflammatory bowel disease with 2-methylene-19-nor-vitamin D compounds
CA2544502A1 (en) * 2003-11-25 2005-06-09 Wisconsin Alumni Research Foundation Vitamin d analogs for obesity prevention and treatment
US7053075B2 (en) * 2003-11-25 2006-05-30 Deluca Hector F Methods for reducing body fat using vitamin D compounds
WO2005079464A2 (en) * 2004-02-17 2005-09-01 Wisconsin Alumni Research Foundation Vitamin d receptor antagonists and their use in treating asthma
US7214671B2 (en) * 2004-02-19 2007-05-08 Wisconsin Alumni Research Foundation Use of 2-methylene-19-nor-20(S)-1α,25-dihydroxyvitamin D3 for the prophylaxis of bone diseases
US7713951B2 (en) * 2004-04-09 2010-05-11 Wisconsin Alumni Research Foundation 2-alkylidene-18,19-dinor-vitamin D compounds
NZ555563A (en) * 2004-11-22 2009-02-28 Wisconsin Alumni Res Found 2-methylene-19-nor-(20S)-1alpha-hydroxy-trishomopregnacalciferol
US7244719B2 (en) * 2004-11-22 2007-07-17 Wisconsin Alumni Research Foundation 2-methylene-19,26,27-trinor-(20S)-1α-hydroxyvitamin D3 and its uses
WO2006057899A2 (en) * 2004-11-22 2006-06-01 Wisconsin Alumni Research Foundation 2alpha-methyl-19-nor-(20s)-1alpha-hydroxy-bishomopregnacalciferol and its uses
NZ555278A (en) * 2004-11-22 2010-12-24 Wisconsin Alumni Res Found 17,20(e)-dehydro vitamin D analogs and their uses
CA2588417C (en) * 2004-11-22 2012-09-18 Wisconsin Alumni Research Foundation 2-methylene-18,19-dinor-1.alpha.-hydroxy-homopregnacalciferol and its uses
CA2588406A1 (en) * 2004-11-22 2006-06-01 Wisconsin Alumni Research Foundation 2-.alpha.-methyl and 2-.beta.-methyl analogs of 19,26,27-trinor-(20s-1.alpha.-hydroxyvitamin d3 and their uses
DK1848442T3 (da) * 2005-02-11 2012-05-29 Wisconsin Alumni Res Found 2-methylene-19-nor-(20s-24epi)-1alfa,25-dihydroxyvitamine-d2
WO2006086613A2 (en) * 2005-02-11 2006-08-17 Wisconsin Alumni Research Foundation 2-METHYLENE-19-NOR- (20S-24S) - 1α, 25-D IHYDROXYVITAMIN-D2
NZ562716A (en) * 2005-03-29 2010-04-30 Wisconsin Alumni Res Found 2-methylene-19-nor-(23S)-25-dehydro-1alpha-hydroxyvitamin D3-26,23-lactone and 2-methylene-19-nor-(23R)-25-dehydro-1alpha-hydroxyvitamin D3-26,23-lactone
US7241909B2 (en) * 2005-05-03 2007-07-10 Wisconsin Alumni Research Foundation 19,26,27-trinor-1α,25-dihydroxyvitamin D3 compounds
WO2008035207A2 (en) * 2006-04-06 2008-03-27 Wisconsin Alumni Research Foundation 2-methylene-1alpha-hydroxy-19,21-dinorvitamin d3 analogs and uses thereof
AU2007349772A1 (en) * 2006-04-06 2008-10-23 Wisconsin Alumni Research Foundation 2-methylene-1alpha,25-dihydroxy-18,19,21-trinorvitamin D3 and uses thereof
AU2007234717B2 (en) * 2006-04-06 2012-04-19 Wisconsin Alumni Research Foundation 2-methylene-1alpha,25-dihydroxy-19,21-dinorvitamin D3 analogs and uses thereof
CA2662992A1 (en) * 2006-09-28 2008-04-03 Wisconsin Alumni Research Foundation 2-methylene-(20r,25s)-19,27-dinor-(22e)-vitamin d analogs
US8377913B2 (en) * 2007-11-20 2013-02-19 Abbvie Inc. Vitamin D receptor activators and methods of making
US8609643B2 (en) * 2007-12-28 2013-12-17 Wisconsin Alumni Research Foundation 2-methylene-(20S,25R)-19,26-dinor-vitamin D analogs
EP2240439B1 (en) * 2007-12-28 2015-03-18 Wisconsin Alumni Research Foundation (20s)-23,23-difluoro-2-methylene-19-nor-bishomopregnacalciferol-vitamin d analogs
JP2011508744A (ja) * 2007-12-28 2011-03-17 ウィスコンシン アラムナイ リサーチ ファンデーション (20r)−23,23−ジフルオロ−2−メチレン−19−ノル−ビスホモプレグナカルシフェロール−ビタミンd類縁体
US8143238B2 (en) * 2008-03-06 2012-03-27 Wisconsin Alumni Research Foundation Methods of increasing epidermal skin thickness by topical administration of a 19-nor containing vitamin D compound
MX2010009814A (es) * 2008-03-10 2010-10-15 Wisconsin Alumni Res Found Compuestos con vitamina d y metodos para reducir la hipertension ocular.
US8193170B2 (en) * 2008-07-10 2012-06-05 Wisconsin Alumni Research Foundation 2-methylene-19,26-dinor-(20R,22E,25R)-vitamin D analogs
US7893043B2 (en) * 2008-07-10 2011-02-22 Wisconsin Alumni Research Foundation 2-methylene-(17Z)-17(20)-dehydro-19,21-dinor-vitamin D analogs
US7888339B2 (en) * 2008-07-10 2011-02-15 Wisconsin Alumni Research Foundation 2-methylene-20(21)-dehydro-19-nor-vitamin D analogs
US8399439B2 (en) * 2008-07-10 2013-03-19 Wisconsin Alumni Research Foundation 2-methylene-19,26-dinor-(20S,22E,25R)-vitamin D analogs
WO2011017165A1 (en) * 2009-08-03 2011-02-10 Wisconsin Alumni Research Foundation Method of preventing renal disease and treating symptoms thereof
MX2012003883A (es) * 2009-10-02 2012-06-27 Wisconsin Alumni Res Found Analogos de (20s,22e)-2-metileno-19-nor-22-ene-1a,25-dihidroxovita mina d3.

Similar Documents

Publication Publication Date Title
JP2009525981A5 (cg-RX-API-DMAC7.html)
JP2010505739A5 (cg-RX-API-DMAC7.html)
JP2009532458A5 (cg-RX-API-DMAC7.html)
EP2854796B1 (en) Combinations of a vascular disrupting agent and a hypoxia-targeting agent for use in the treatment of cancer
RU2019101632A (ru) Наночастица, содержащая рапамицин и альбумин, в качестве противоракового агента
JP2009536191A5 (cg-RX-API-DMAC7.html)
WO2010129864A3 (en) Methods and compositions for studying, imaging, and treating pain
JP2010540555A5 (cg-RX-API-DMAC7.html)
JP2007502832A5 (cg-RX-API-DMAC7.html)
JP2013522369A5 (cg-RX-API-DMAC7.html)
RU2014108885A (ru) Ингибирование транзиторного рецепторного потенциала ионного канала trpa1
JP2007504168A5 (cg-RX-API-DMAC7.html)
JP2008520703A5 (cg-RX-API-DMAC7.html)
JP2006510658A5 (cg-RX-API-DMAC7.html)
JP2013522370A5 (cg-RX-API-DMAC7.html)
JP2008520705A5 (cg-RX-API-DMAC7.html)
JP2002544227A5 (cg-RX-API-DMAC7.html)
JP2006523239A5 (cg-RX-API-DMAC7.html)
JP2011527695A5 (cg-RX-API-DMAC7.html)
JP2014520101A5 (cg-RX-API-DMAC7.html)
JP2011527699A5 (cg-RX-API-DMAC7.html)
JP2008525493A5 (cg-RX-API-DMAC7.html)
RU2007104176A (ru) Синтез и применение (-)-бета-элемена, (-)-бета-элеменала, (-)-бета-элеменола, фторида (-)-бета-элемена и их аналогов, а также промежуточных продуктов и композитов
JP2009533483A5 (cg-RX-API-DMAC7.html)
JP2011527696A5 (cg-RX-API-DMAC7.html)